You are here: Industry Insights > cancer

News List

Cancer Genetics acquires vivoPharm for $12 million USD biospectrumasia
August 23, 2017
This transaction will significantly strengthen CGI's position as a premier leader for oncology discovery, in vivo and in vitro drug development and early phase clinical trial testing for biotechnology and pharmaceutical companies
New personalised molecular blood test could shake up cancer treatment pharmafile
August 17, 2017
A team of researchers at Stanford University have engineered a new, highly-sensitive molecular test to detect and monitor cancer
NICE approves three quarters of the Cancer Drugs Fund europeanpharmaceuticalreview
August 15, 2017
NICE has recommended sorafenib to be routinely available for patients on the NHS making it one of the 24 drugs appraised from the CDF…
Takeda and Shattuck Labs partner to develop immunotherapies for cancer treatments pharmaceutical-technology
August 15, 2017
Takeda Pharmaceutical has entered a research collaboration with Shattuck Labs to study and develop checkpoint fusion proteins that have the potential to be used as highly differentiated, advanced immunotherapies for cancer.
Biotech to drive biggest cancer advancements in decades – report pharmatimes
August 11, 2017
A new report on the prospects of immunotherapy treatments has identified smaller, nimble biotechs and early stage companies as the single biggest factor behind the next generation of approaches in development.
Cancer Research UK and Biotecnol to trial new immunotherapy pharmatimes
August 11, 2017
A new collaboration agreement between Cancer Research UK and Biotecnol will see an experimental immuno-oncology treatment move into early phase clinical trials for patients with advanced solid tumours, including lung cancers.
WuXi AppTec promotes prospects of immunotherapy biospectrumasia
August 11, 2017
Over the next 10-years, we will see significantly greater breakthroughs as the industry’s understanding of the immune system improves.
FDA awards orphan status to new brain cancer vaccine pharmafile
August 10, 2017
The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the most common form of brain cancer and a condition which affects 14,000 new patients in the US every month.
BookDoc associates with Singapore Cancer Society biospectrumasia
August 10, 2017
Under this collaboration, services offered by SCS at no cost, such as Pap smear, Mammogram and Faecal Immunochemical Test, can now be searched through BookDoc's free Apps and Website, BookDoc.com.
Invitrouce and GIS launch innovations lab to advance personalized medicine for cancer treatment biospectrumasia
August 10, 2017
Invitrouce and GIS launch innovations lab to advance personalized medicine for cancer treatment The joint laboratory will leverage GIS’ expertise in genomics, oncology and organoid biology, and ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page